BioHarvest Sciences Inc. ... (BHST)
| Bid | 6.75 |
| Market Cap | 122.35M |
| Revenue (ttm) | 27.68M |
| Net Income (ttm) | -8.66M |
| EPS (ttm) | -0.45 |
| PE Ratio (ttm) | -15.69 |
| Forward PE | 115.83 |
| Analyst | Buy |
| Ask | 9 |
| Volume | 3,045 |
| Avg. Volume (20D) | 23,838 |
| Open | 6.97 |
| Previous Close | 6.95 |
| Day's Range | 6.77 - 7.10 |
| 52-Week Range | 4.66 - 7.86 |
| Beta | 1.29 |
About BHST
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for BHST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 weeks ago · proactiveinvestors.com
BioHarvest Sciences launches Informed Sport-certified daily chew - ICYMIBioHarvest Sciences Inc. (NASDAQ:BHST) CEO Ilan Sobel talked with Proactive about the company's newest addition to its Vinia product line, a daily “2X formula” chew, specifically designed for athletes...
2 weeks ago · proactiveinvestors.com
BioHarvest Sciences launches Informed Sport-certified VINIA DailyChews 2X FormulaBioHarvest Sciences Inc. (NASDAQ:BHST) has launched a new product tailored to athletes and individuals with active lifestyles called VINIA DailyChews 2X Formula. The developer of botanical-based welln...
1 month ago · proactiveinvestors.com
BioHarvest inks fragrance compound deal in move into multi-billion-dollar scents marketBioHarvest Sciences Inc. (NASDAQ:BHST) said it has signed a contract to develop a plant-based fragrance compound using its patented Botanical Synthesis technology, marking the company's entry into the...
1 month ago · proactiveinvestors.com
BioHarvest Sciences advances CDMO deal with major pharmaceutical company - ICYMIBioHarvest Sciences Inc. (NASDAQ:BHST) CEO Ilan Sobel joined Proactive to discuss the company's transition to stage two of its partnership with a pharmaceutical company. This marks a key milestone in ...
